A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit
- PMID: 12487369
- DOI: 10.1023/a:1020679809056
A selective somatostatin type-2 receptor agonist inhibits neointimal thickening and enhances endothelial cell growth and morphology following aortic balloon injury in the rabbit
Abstract
Somatostatin analogs have been shown to inhibit vascular smooth muscle cell (VSMC) proliferation and attenuate neointimal thickening following experimental balloon catheter injury. In this study, the effects of a selective agonist for the somatostatin receptor subtype 2, PRL-2486, on neointimal thickening and endothelial cell regrowth 2 weeks following balloon catheterization of male New Zealand White rabbits were determined. Rabbits treated 2 days prior to and 2 weeks after catheter injury with 10 microg/kg/day PRL-2486 (PRL-tx) had decreased I/M ratios (intimal area/medial area x 100; p < 0.05) but had no effect at lower (5 microg/kg/day) or higher (20 microg/kg/day) doses. PRL-tx had significantly decreased VSMC proliferation compared to untreated animals. PRL-tx increased endothelial regrowth by over 2-fold (p < 0.002) and improved endothelial cell morphology. Endothelial-dependent relaxation responses to acetylcholine were attenuated by catheter injury, and were not improved with PRL-tx. These data suggest that the PRL-2486-mediated inhibition of neointimal thickening exhibits a bell-shaped dose-response curve. This inhibition may be due in part to decreased VSMC proliferation, which may be a function of enhanced endothelial regrowth, but not the return of endothelium-dependent vascular function.
Similar articles
-
U74389F, a 21-aminosteroid antioxidant, improves neoendothelial morphology, but not neointimal thickening after balloon catheter injury.Can J Physiol Pharmacol. 2009 Dec;87(12):1102-9. doi: 10.1139/Y09-109. Can J Physiol Pharmacol. 2009. PMID: 20029547
-
Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits.Am J Physiol. 1999 Aug;277(2):H740-8. doi: 10.1152/ajpheart.1999.277.2.H740. Am J Physiol. 1999. PMID: 10444501
-
Estradiol inhibition of arterial neointimal hyperplasia after balloon injury.J Vasc Surg. 1994 Apr;19(4):722-6. doi: 10.1016/s0741-5214(94)70047-8. J Vasc Surg. 1994. PMID: 7909339
-
Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis.Cardiovasc Res. 2000 Aug 18;47(3):436-45. doi: 10.1016/s0008-6363(00)00091-2. Cardiovasc Res. 2000. PMID: 10963717 Review.
-
Oestradiol inhibition of vascular myointimal proliferation following immune, chemical and mechanical injury.Ciba Found Symp. 1995;191:139-45; discussion 145-9. doi: 10.1002/9780470514757.ch8. Ciba Found Symp. 1995. PMID: 8582194 Review.
Cited by
-
The State-of-the-Art Mechanisms and Antitumor Effects of Somatostatin in Colorectal Cancer: A Review.Biomedicines. 2024 Mar 5;12(3):578. doi: 10.3390/biomedicines12030578. Biomedicines. 2024. PMID: 38540191 Free PMC article. Review.
-
Somatostatin Primes Endothelial Cells for Agonist-Induced Hyperpermeability and Angiogenesis In Vitro.Int J Mol Sci. 2022 Mar 13;23(6):3098. doi: 10.3390/ijms23063098. Int J Mol Sci. 2022. PMID: 35328517 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources